An interventional study of Exercise training in the fasted state and Exercise training in the fed state in Cardiovascular Diseases, Diabetes Mellitus, Type 2 and Obesity, sponsored by Manchester Metropolitan University. Recruiting at 1 site in United Kingdom. Open to participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-03-07.
Sponsored by Manchester Metropolitan University · Not applicable, Interventional, and Basic science
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The aim of this randomised control trial is to investigate the role of fasted exercise on cardiometabolic health. Participants will be assigned to one of three conditions, fasted exercise, fed exercise and control (no exercise). Participants in the exercise groups will complete four weeks of moderate intensity cycling exercise, three times per week, either in the fasted or fed state according to their group assignment. Experimental trials involving anthropometric and cardiometabolic disease risk factor measurements as well as metabolic responses to a subsequent meal ingestion following exercise will be compared pre-intervention and post intervention.
The aim of this study is to investigate the effect of fasted exercise on cardiometabolic health and the potential mediatory role of sirtuins.
The objectives are to investigate:
A randomised control trial will be conducted with volunteers allocated under the conditions of a) no exercise (control), b) fasted exercise training (FASTEX) and c) fed exercise training (FEDEX). The pre- and post-intervention visits will consist of 50 minutes of cycling at a moderate exercise intensity for both the FASTEX and FEDEX groups. The control group would not perform any exercise. The FASTEX group will perform the exercise in the fasted state, whilst the FEDEX and control groups will be fed a standardised breakfast meal one hour in advance of the exercise period. Following the exercise period, the participants will be fed a high fat meal and metabolic responses to the meal will be measured for four hours. Multiple blood samples will be obtained as well as a sample of subcutaneous adipose (fat) tissue. The FASTEX and FEDEX groups will then complete four weeks of moderate intensity continuous exercise training, either fasted or fed according to their group, on three days per week whilst the control group will maintain their normal sedentary lifestyle. All participants will return to the laboratory for post-intervention testing at the end of the four weeks with the same protocols and measurements as the pre-intervention testing.
5,376 studies on the registry are indexed under Cardiovascular Diseases; 940 are open to participants now.
This study's planned enrollment of 30 is below the median of 100 across 3,086 interventional studies indexed under Cardiovascular Diseases.
Browse Cardiovascular Diseases studies →Manchester Metropolitan University is the lead sponsor of 19 studies on the registry; 7 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Hypersensitivity
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Exercise training in the fasted state
Other: Exercise training in the fasted state
Exercise training in the fed state
Other: Exercise training in the fed state
No exercise training
Four weeks of moderate intensity cycling exercise, three times a week without eating breakfast meal
Four weeks of moderate intensity cycling exercise, three times a week, after eating breakfast meal
Changes in circulating concentrations of key metabolic markers following a high fat lunch meal
Serum concentrations of clinical chemistry blood analytes (glucose, triglycerides, cholesterol)
Time frame: 9 blood samples collected at pre-meal ingestion then every 30 min after ingestion for four hours
Changes in circulating concentrations of key metabolic markers during the experimental trial day
Serum concentrations of clinical chemistry blood analytes (glucose, triglycerides, cholesterol)
Time frame: 12 blood samples collected at 0 (baseline), 75 (pre-exercise), 125 (immediately post-exercise), 155 min (pre-meal ingestion) then every 30 min after ingestion for four hours
Area under the circulating concentration versus time curve (AUC) of key metabolic markers following a high fat lunch meal
Total responses of clinical chemistry blood analytes (glucose, triglycerides, cholesterol)
Time frame: 4.5 hours
Changes in cardiovascular and metabolic disease biochemistry risk factors
Fasted serum concentrations of clinical chemistry blood analytes (glucose, blood lipids, inflammatory markers)
Time frame: 4 weeks (pre and post intervention)
Changes in cardiovascular disease physiological risk factors
Systolic and diastolic blood pressure and calculation of mean arterial pressure using systolic and diastolic values
Time frame: 4 weeks (pre and post intervention)
Changes in concentration of sirtuin molecules
Serum concentrations of sirtuins
Time frame: 4 weeks (pre and post intervention)
Changes in sirtuin molecule gene expression
Adipose tissue gene expression of sirtuins
Time frame: 4 weeks (pre and post intervention)
Changes in sirtuin molecule tissue expression
Adipose tissue expression and cellular localisation of sirtuins
Time frame: 4 weeks (pre and post intervention)
Changes in cardiovascular and metabolic disease anthropometric risk factors
Waist circumference, hip circumference and waist:hip ratio
Time frame: 4 weeks (pre and post intervention)
Change in body composition
Body fat percentage measured using bioelectrical impedance analysis
Time frame: 4 weeks (pre and post intervention)
Change in body mass
Body mass in kilograms
Time frame: 4 weeks (pre and post intervention)
Change in substrate oxidation during the experimental trial day
Carbohydrate and fat oxidation through indirect calorimetry
Time frame: 17 measurements at 0 (baseline), 15 (post-breakfast meal period), 45 (30 min post-breakfast meal period), 75 (pre-exercise), every 10 min during exercise, 155 (pre-meal ingestion), then every 30 min for four hours.
Heart rate response to exercise
Heart rate during exercise in the experimental trial using telemetry
Time frame: At rest before exercise then every 5 min during 50 min cycle exercise
Perceived exertion
Rating of perceived exertion of exercise in the experimental trial using Borg scale
Time frame: Every 5 min during 50 min cycle exercise
Change in physical activity levels
Physical activity energy expenditure during the intervention period
Time frame: Daily for 4 weeks
Change in physical activity duration
Amount of time spent performing physical activity at different intensities (low, moderate, high) during the intervention period
Time frame: Daily for 4 weeks
Change in energy intake
Energy intake using weighed food diary record during the intervention period
Time frame: Daily for 4 weeks
Change in dietary nutritional intake
Macronutrient (carbohydrate, fat, protein) composition of food intake using weighed food diary record during the intervention period
Time frame: Daily for 4 weeks
Plan to share: No — Planned communication of group results at a scientific conference. Planned publication in a scientific peer reviewed journal. Participant level data is not expected to be available as this complies with the conditions of the ethical approval granted for this study.
No publications or documents are linked to this record.
Started Mar 2023 (actual). Primary completion is estimated for Apr 2025, 25 months after the start.
Of 1,081 non-industry interventional studies with no phase under Cardiovascular Diseases, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 48. This study's planned 25 months is close to that.
Counting every sponsor, half of 1,220 studies reached it within 26 months; a quarter within 12 and three quarters within 49.
Cardiovascular Diseases covers many different conditions, not one, so the studies compared here vary widely. Read these figures as a rough guide.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Manchester Metropolitan University